Gaining new market segments in clinical diagnostics – globally unique position as system supplier in laboratory diagnostics sector Darmstadt, June 7, 2022 – R-Biopharm AG, a leading German biotechnology company operating on a global scale, announced the acquisition of AusDiagnostics. R-Biopharm is expanding its product portfolio with the addition of the Australian specialist and manufacturer …

R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics Read More »

Digital Catapult publishes Sellafield Distributed Ledger Technology Field Lab report Cambridge, UK – July 12, 2022 – Zero trust fabric provider RKVST has shown how it can help safely and securely digitise processes for nuclear waste data tracking, creating a secure, irrefutable way to maintain the integrity of data while ensuring visibility for multiple stakeholders …

RKVST shows the future of nuclear waste tracking with Zero Trust Fabric Read More »

The Emotet comeback continues as threat actors target SCADA systems 28 September 2022: The latest Internet Security Report from the WatchGuard Threat Lab, shows a reduction in overall malware detections from the peaks seen in the first half of 2021, along with an increase in threats for Chrome and Microsoft Office and the ongoing Emotet …

WatchGuard Threat Lab Reports Decrease in Malware Volume, Surge in Encrypted Malware and Actively Exploited Office Vulnerabilities Read More »

Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally Munich / London / Athens, March 20th, 2023 – Munich-based pharmaceutical contract development organization (CDMO) Adragos Pharma GmbH …

Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories Read More »

The National Physical Laboratory (NPL), today announces the selection of three innovation nodes in partnership with the University of Strathclyde, University of Surrey, and Cranfield University. These innovation nodes are being developed in partnership between NPL and the host organisations and will enable the application of timing and frequency across any sector. These locations, chosen …

The National Physical Laboratory (NPL) announces the selection of three Innovation Nodes as part of its National Timing Centre (NTC) programme Read More »

Aachen, Germany, and Raleigh, North Carolina – USA, 29 March 2022 – Grünenthal and NovaQuest announced today that they have entered into an agreement to advance the global clinical Phase III programme of Grünenthal’s asset resiniferatoxin (RTX). The investigational medicine is being developed with the aim of providing patients suffering from pain associated with osteoarthritis …

Grünenthal and NovaQuest enter agreement to advance the resiniferatoxin global Phase III program in osteoarthritis Read More »